Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R2CF
|
|||
| Former ID |
DNC013402
|
|||
| Drug Name |
7-(3,5-dimethoxyphenyl)-1,6-naphthyridine
|
|||
| Synonyms |
CHEMBL236262; 7-(3,5-dimethoxyphenyl)-1,6-naphthyridine; MLS002402797; HMS3344J20; HMS2201J14; BDBM50224927
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H14N2O2
|
|||
| Canonical SMILES |
COC1=CC(=CC(=C1)C2=NC=C3C=CC=NC3=C2)OC
|
|||
| InChI |
1S/C16H14N2O2/c1-19-13-6-12(7-14(8-13)20-2)16-9-15-11(10-18-16)4-3-5-17-15/h3-10H,1-2H3
|
|||
| InChIKey |
HVIBISIIVPOREN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6525-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.